ICL 2.1: Fixed Obstructive Lung Disease: COPD and Bronchiectasis Flashcards

1
Q

what is COPD?

A

a persistent respiratory symptoms and fixed airflow limitation that is due to both airway and/or alveolar abnormalities

usually caused by significant exposure to noxious particles or gases; especially cigarette smoke

a common, preventable and treatable disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the causes of COPD?

A
  1. cigarette smoking
  2. biomass fuel used in cooking
  3. genetic predisposition
  4. SE status
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the prevalence of COPD?

A

3rd leading cause of death in the US

leading cause of morbidity and mortality worldwide

prevalence is projected to increase in coming decades to do increased exposure to risk actors and population aging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the pathogenesis of COPD?

A

enhancement of the normal physiological inflammatory response of the respiratory tract to chronic irritants

primarily TH1/neotrophil and macrophage inflammation in comparison to asthma which is primarily tH2/eosinophil/mast cell inflammation

mechanisms for amplified inflammation in the 10-15% of heavy smokers who develop COPD is not understood

lung inflammation persists after smoking cessation and defective airway clearance allows nasal bacterial flora to colonize airways which exacerbate inflammation = pneumococcus, H. influenza, M. catarrhalis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the pathophysiology of COPD?

A
  1. airflow limitation
  2. gas trapping
  3. hyperinflation

narrowing of peripheral airways is due to inflammation and irritation plus reduced elastic recoil due to parenchymal destruction

  1. hypoxia and hypercapnia due to V/Q mismatch
  2. mucus hyper secretion due to increased number of goblet cells and enlarged submucosal glands in response to chronic airway irritation
  3. pulmonary HTN due to hypoxic vasoconstriction of small arteries
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the pathophysiologic cause of air trapping seen with COPD?

A

air trapping in alveoli is caused by collapse of small airways, not the alveoli themselves

breakdown of alveoli connections to adjacent small airways removes support necessary to prevent early collapse during exhalation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the effect of increased airway resistance/obstruction on breathing seen in COPD?

A
  1. sharply reduced effort-independent air flow at high volume than in normal
  2. air is trapped in alveoli due to slow flow resulting from obstruction during end expiration

air trapping raises alveolar pressure and trans pulmonary pressure which causes the diaphragm to become flattened and it’s no longer able to generate inspiratory pressures high enough to overwhelm the transpulmonary pressure

reduced function of the diaphragm and high lung pressures increase the work of breathing…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

when should you be suspicious that someone has COPD?

A
  1. dyspnea
  2. chronic cough or sputum production
  3. h/o exposure to risk factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how do you diagnose COPD?

A

spirometry is REQUIRED to make the diagnosis

post-bronchodilator FEV1/FVC < 0.70 confirms fixed airflow limitation = COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

which of the following is correct regarding altered mechanism of breathing in COPD?

A. collapse of alveoli at higher than normal lung volumes is associated with air trapping and hyperinflation

B. increased alveolar elastic recoil is associated with collapse of small airways at higher lung volumes

C. an FEV1/FVC of 0.8 is consistent with COPD

D. an FEV1/FVC of .5 prior to bronchodilator is consistent with COPD

A

A. collapse of alveoli at higher than normal lung volumes is associated with air trapping and hyperinflation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how do you diagnose chronic bronchitis?

A

mostly history based:

  1. productive cough that lasts at least 3 months over a period of at least 2 years
  2. polycythemia = increased RBCs
  3. hypxemia which leads to increased EPO levels

so you diagnose COPD based on FEB1/FVC > 0.7 first and then you specifically diagnose chronic bronchitis in a COPD patient based on their history of a cough for 2+ years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how do you diagnose emphysema?

A

based on structural changes:

  1. CXR ro CT which shows: enlargement or air oscar, increased AP diameter, flattened diaphragm, increased lung field lucency
  2. DLCO: decreased lung diffusing capacity secondary to alveolar wall destruction
  3. decreased alpha-1 antitrypsin

so you diagnose COPD based on FEV1/FVC < 0.7 first and then you diagnose emphysema specifically based on imaging showing structural changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which of the following is correct regarding chronic bronchitis and emphysema sub-types of COPD?

A. CPD and chronic bronchitis are each diagnosed based on a combination of history, PE, PFT, and imaging

B. each COPD patient has primarily either chronic bronchitis or COPD, not a combination of both

C. in patients with FEV1/FVC below 0.7, a consistent history is what provides diagnosis of chronic bronchitis

D. the key determinant of whether a COPD patient is a blue bloater or pink puffer is the degree of obstruction

A

C. in patients with FEV1/FVC below 0.7, a consistent history is what provides diagnosis of chronic bronchitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what’s the difference between a blue bloater and pink puffer?

A

chemoreceptor sensitivity!

blue bloaters have less intense ventilatory response to CO2 resulting in hypoventilation –> as a consequence they have a high PaCO2, lower PaO2, and a higher Hb due to secondary polycythemia – they often have cor pulmonale due to chronic hypoxia vasoconstriction resulting in pulmonary HTN and subsequently lower extremity edema from CHF

punk puffers have a more intense ventilatory response to increased CO2 levels so they have proper ventilation, normal PCO2 and normal oxygen levels so they aren’t cyanotic and remain pink

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

chronic bronchitis has similar features to what other condition?

A

obstructive sleep apnea/obesity hypoventilation syndrome = Pickwickian syndrome

both of them have hypoventilation due to less sensitive response to increased CO2 levels

so they both have high PaCO2, low PaO2, and high Hb as a result of secondary polycythemia

cor pulmonale response from chronic hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how do you asses COPD severity?

A
  1. asses airway limitation based on FEV1/FVC then it’ll be classified as mild, moderate, severe or very severe based on FEV1% compared to predicted below 80% to varying degrees
  2. asses symptoms based on questionaries = modified british medical research council questionnaire and the COPD assessment test –> if the mMRC and CAT disagree use the worse score to determine symptom value
  3. assess past frequency of exacerbations based on history

if airflow limitation assessment and exertion risk differ, use worse value to determine risk value

17
Q

in determining GOLD stage of COPD severity which of the following statements is correct?

A. symptoms severity is based on a summation of CAT and mMRC questionnaire scores

B. risk of COPD exacerbation is based on a combination of exacerbation history and airflow measured by spirometry

C. if there is a discrepancy between exacerbation history and the airflow limitation measured by FEB1, whichever one is associated with a higher risk is used to determine GOLD stage

D. individual with CAT score of 5, FEV1 of 0.75, and more than 4 exacerbations per year would have a GOLD stage of A

A

C. if there is a discrepancy between exacerbation history and the airflow limitation measured by FEB1, whichever one is associated with a higher risk is used to determine GOLD stage

eh go look at the chart

18
Q

how do you treat GOLD A COPD?

A

bronchodilator

GOLD A = low symptoms and relatively preserved airflow and few/no exacerbations

19
Q

how do you treat GOLD B COPD?

A

long-acting bronchodilator like LABA or LAMA

if there are persistent symptoms you can use both

so this is people who have a lot of symptoms, few exacerbations and airflow is preserved

20
Q

how do you treat GOLD C COPD?

A

LAMA

if there’s further exacerbations give LAMA + LABA and if you absolutely have to you can give LABA + inhaled corticosteroid

this is patents with airflow limitations, few symptoms, and lots of exacerbations

21
Q

how do you treat GOLD D COPD?

A

LAMA + LABA or LABA + ICS

if there’s further exacerbation give LAMA+LABA+ICS

consider macrolides in former smokers or roflumilast in FEV1 <50% to reduce mucus production

this is for people with a lot of airflow limitations and symptoms and exacerbation

22
Q

what are the indications for oxygen treatment in COPD?

A

resting pO2 < 55, O2 saturation <88% or pO2 <59 in presence of cor pulmonale

oxygen supplementation for these subjects decreases mortality!! this is the only treatment that decreases mortality!! the others just improve QOL and decrease exacerbations

desaturation below 88% with exercise or sleep you should also give oxygen supplementation but it doesn’t decrease mortality, it just improves QOL

23
Q

which of the following is true regarding effect of treatment on COPD mortality?

A. a combination of LABA, AMA and ICS reduces mortality of GOLD stage D COPD

B. supplemental oxygen provided 18+ hours/day reduces mortality in patients with resting oxygen tension less than pO2 of 55

C. supplemental oxygen provided 24 hrs/day reduces mortality in all COPD patients

D. all of the above

A

aB. supplemental oxygen provided 18+ hours/day reduces mortality in patients with resting oxygen tension less than pO2 of 55

24
Q

what is COPD exacerbation?

A

a sustained worsening of the patient’s stable state condition

acute in onset and may warrant additional treatment

they are a feature of moderate to severe disease and are more frequent in those with regular sputum production (chronic bronchitis, no emphysema)

best predictor of future exacerbation is frequency of past exacerbations

1.5 million ED visits and 700,000 hospitalizations a year in the US are caused by this!

25
Q

what are the characteristics of COPD exacerbation?

A
  1. increased airway inflammation due to infection, environmental pollutants, other
  2. increased hyperinflation and gas trapping
  3. reduced expiratory flow and increased dyspnea
  4. increased V/Q mismatching = hypoxemia and hypercarbia
26
Q

what causes COPD exacerbation?

A

80% infection

  • 40% bacterial = H. influenza, S. pneumonia, M catarrhalis are in the nasal flora!
  • 40% viral = rhinovirus, RSV, influenza, parainfluenza, covid, adenovirus

20% non-infectious = PE, CHF, acute coronary ischemia, allergies, smoking, pollution, non-compliance

27
Q

55 year old woman presented with increasing severity of wheezing and coughing of whitish chunks. what is the most likely cause of presentation?

A. bronchiectasis with atypical mycobacterial superinfection

B. bronchiectasis with pseudomonas superinfection

C. CF

D. allergic bronchopulmonary aspergillosis

A

A. bronchiectasis with atypical mycobacterial superinfection

28
Q

how do you treat COPD exacerbation?

A
  1. antibiotic in those with infectious symptoms
  2. treat nasal flora colonizers of the airway = pneumococcus, H. influenza, M catarrhalis
  3. systemic steroid for 5 days only
  4. supplemental controlled oxygen through Venturi mask and check with ABG – maintain O2 >88% and respiratory rate <45
  5. asses for CHF decompensation, pneumonia, PE, OSA, OHA, GERD with recurrent aspiration
29
Q

what other things are in the differential for COPD exacerbation? how would you differentiate them?

A
  1. CHF –> imaging will show dilated heart, pulmonary edema, effusion, PFT not supportive
  2. bronchiectasis –> large volumes of purulent sputum, commonly associated with bacterial infections
  3. asthma –> early onset, variation in symptoms and worse at night, allergies, eczema
  4. COPD –> midlife onset, symptoms, slowly progressive, h/o tobacco

uncontrolled OSA exacerbates ALL o these and is common!!

30
Q

what is bronchiectasis?

A

obstructive lung disease

CF accounts for 10% of bronchiectasis

commonly co-diagnosed with COPD and asthma

non-tuberculosis mycobacteria, aspergillous and pseudomonas is a common super-infection and/or cause

31
Q

65 year old presents with severe COPD with increased work of breathing, hypoxia, tachypnea with prolonged expiratory time and after aggressive treatment needs to be admitted. which of the follow is correct regarding severe COPD exacerbations?

A. about 90% of COPD exacerbations are caused by viral infection and therefore should not be treated with empiric antibiotics

B. exacerbations are more common in COPD patients with emphysema sub-type

C. pulmonary embolism accounts for significant fraction of COPD exacerbations among those sick enough to be admitted

D. the likelihood of future exacerbations is predicted by past exacerbation frequency but not related to severity of airway obstruction

A

C. pulmonary embolism accounts for significant fraction of COPD exacerbations among those sick enough to be admitted